SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-019825
Filing Date
2023-05-09
Accepted
2023-05-09 17:01:02
Documents
79
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q crbp-20230331.htm   iXBRL 10-Q 2020164
2 EX-31.1 crbp-ex31_1.htm EX-31 21035
3 EX-31.2 crbp-ex31_2.htm EX-31 21231
4 EX-32.1 crbp-ex32_1.htm EX-32 12390
5 EX-32.2 crbp-ex32_2.htm EX-32 12418
  Complete submission text file 0000950170-23-019825.txt   9793740

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crbp-20230331.xsd EX-101.SCH 58259
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT crbp-20230331_def.xml EX-101.DEF 217685
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crbp-20230331_lab.xml EX-101.LAB 494654
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT crbp-20230331_cal.xml EX-101.CAL 51257
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crbp-20230331_pre.xml EX-101.PRE 404472
73 EXTRACTED XBRL INSTANCE DOCUMENT crbp-20230331_htm.xml XML 2197698
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37348 | Film No.: 23903122
SIC: 2834 Pharmaceutical Preparations